ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS THE INFORMATION CALLED FOR BY THIS ITEM IS INCORPORATED HEREIN BY REFERENCE TO THE NARRATIVE AND TABULAR (BUT NOT THE GRAPHIC) MATERIAL INCLUDED IN THE MATERIAL CAPTIONED "MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION" ON PAGES 26 THROUGH 32 OF JOHNSON & JOHNSON'S ANNUAL REPORT TO SHAREOWNERS FOR FISCAL YEAR 2000. ON MARCH 27, 2001, THE COMPANY ANNOUNCED THAT IT HAD ENTERED INTO A DEFINITIVE MERGER AGREEMENT WITH ALZA CORPORATION, A RESEARCH-BASED PHARMACEUTICAL COMPANY AND A LEADER IN DRUG DELIVERY TECHNOLOGIES. ALZA SHAREHOLDERS WILL RECEIVE A FIXED EXCHANGE RATIO OF .49 SHARES OF JOHNSON & JOHNSON COMMON STOCK FOR EACH SHARE OF ALZA IN A TAX-FREE TRANSACTION. ON A FULLY DILUTED BASIS, ALZA HAS APPROXIMATELY 295 MILLION SHARES OUTSTANDING. JOHNSON & JOHNSON INTENDS TO ACCOUNT FOR THE TRANSACTION AS A POOLING OF INTERESTS. THE BOARDS OF DIRECTORS OF THE COMPANY AND ALZA HAVE GIVEN APPROVALS TO THE MERGER. WHILE THE TRANSACTION IS EXPECTED TO CLOSE BY THE EARLY PART OF THE THIRD QUARTER OF 2001, THE MERGER IS SUBJECT TO CLEARANCE UNDER THE HART-SCOTT-RODINO ANTITRUST IMPROVEMENTS ACT AND THE EUROPEAN UNION MERGER CONTROL REGULATION, AND OTHER CUSTOMARY CLOSING CONDITIONS. THE AGREEMENT WILL ALSO REQUIRE THE APPROVAL OF ALZA'S SHAREHOLDERS. ON JANUARY 26, 2001, THE COMPANY ANNOUNCED THAT IT HAD ENTERED INTO A DEFINITIVE AGREEMENT TO ACQUIRE HEARTPORT, INC., A MANUFACTURER OF LESS INVASIVE CARDIAC SURGERY PRODUCTS. THE TRANSACTION IS VALUED AT 6 <PAGE> 9 APPROXIMATELY $81 MILLION. HEARTPORT, INC. DEVELOPS, MANUFACTURES AND SELLS LESS INVASIVE CARDIAC SURGERY PRODUCTS THAT ENABLE SURGEONS TO PERFORM A WIDE RANGE OF LESS INVASIVE OPEN-CHEST AND MINIMALLY INVASIVE HEART OPERATIONS. THE COMPANIES EXPECT THE TRANSACTION TO BE COMPLETED DURING THE SECOND QUARTER OF 2001, SUBJECT TO CUSTOMARY CONDITIONS, INCLUDING APPROVAL BY A MAJORITY OF THE SHAREOWNERS OF HEARTPORT AND HART-SCOTT-RODINO CLEARANCE. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK THE INFORMATION CALLED FOR BY THIS ITEM IS INCORPORATED HEREIN BY REFERENCE TO THE MATERIAL CAPTIONED "MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION -- FINANCIAL INSTRUMENTS" ON PAGE 31 OF JOHNSON & JOHNSON'S ANNUAL REPORT TO SHAREOWNERS FOR FISCAL YEAR 2000. 